Covista (CVSA) Cash & Equivalents (2009 - 2026)

Covista (CVSA) has reported Cash & Equivalents for 18 consecutive years, with $147.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 6691.91% year-over-year to $147.0 million; the TTM figure through Mar 2026 stood at $147.0 million (up 6691.91% YoY), while the FY2025 annual figure was $1.6 million, down 17.56% from the prior year.
• Cash & Equivalents advanced to $147.0 million in Q1 2026 per CVSA's latest filing, from $2.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $788.7 million in Q1 2022 and bottomed at $1.5 million in Q4 2024.
• Historically, Cash & Equivalents has averaged $163.6 million across 5 years, with a median of $147.0 million in 2026.
• On a YoY basis, Cash & Equivalents climbed as much as 7255.5% in 2024 and fell as far as 99.3% in 2024.
• Covista's Cash & Equivalents stood at $3.7 million in 2022, then surged by 4808.59% to $182.9 million in 2023, then slumped by 99.2% to $1.5 million in 2024, then jumped by 61.46% to $2.4 million in 2025, then surged by 6130.48% to $147.0 million in 2026.
• Business Quant data shows CVSA's Cash & Equivalents at $147.0 million in Q1 2026, $2.4 million in Q4 2025, and $264.7 million in Q3 2025.